Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Patrick Holman"'
Autor:
Kevin Eng, Ryan Lau, Scott Oh, Catherine Oberg, Jay Lee, Reza Ronaghi, Peyman Benharash, Jaime Betancourt, Patrick Holman
Publikováno v:
Chest. 160:A2059-A2060
Publikováno v:
Current Cardiology Reports
Current cardiology reports, vol 23, iss 3
Current cardiology reports, vol 23, iss 3
Purpose of Review Immunotherapies have demonstrated robust clinical efficacy in treating malignancies with increasing use and FDA approvals. We review the epidemiology, risk factors, diagnosis, and treatment of immunotherapy-associated cardiovascular
Publikováno v:
Chest. 158:A1925-A1926
Autor:
Chih-Min Tang, Phillippe Foubert, Evangeline Mose, Andrew M. Lowy, Dawn Jaquish, Michele L. Babicky, Megan M. Harper, Alex Cazes, Michael C. Schmid, Karen Messer, Patrick Holman, Randall French, Jaclyn Miyamoto, Susan E. Waltz, Judith A. Varner, Zakkary J Walterscheid, Jeffery Chakedis, Nissi Varki, Hakan Alakus, Betzaira G. Childers, Jason K. Sicklick
Publikováno v:
ONCOGENE
Oncogene, vol 38, iss 28
Oncogene
Oncogene, vol 38, iss 28
Oncogene
The MST1R (RON) kinase is overexpressed in >80% of human pancreatic cancers, but its role in pancreatic carcinogenesis is unknown. In this study, we examined the relevance of Mst1r kinase to Kras driven pancreatic carcinogenesis using genetically eng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebbd059e2304724657496e421fcd5c30
Publikováno v:
Blood. 136:9-9
Introduction: CD19-targeting chimeric antigen receptor (CAR) T cell therapy has generated robust clinical responses in the treatment of relapsed and refractory hematological malignancies. While CAR T cell toxicity in the form of cytokine release synd
Autor:
Paula Porras, Zakk Walterscheid, Dawn Jaquish, Jan Eickhoff, Michele L. Babicky, Evangeline Mose, Jeffery Chakedis, Andrew M. Lowy, Peter Cheng, Carsten Schultz-Fademrecht, Oliver Schadt, Randall French, Haleigh Howard, Christina Esdar, Jaclyn Miyamoto, Patrick Holman
Publikováno v:
Oncotarget
// Jeffery Chakedis 1 , Randall French 1 , Michele Babicky 1 , Dawn Jaquish 1 , Evangeline Mose 1 , Peter Cheng 1 , Patrick Holman 1 , Haleigh Howard 1 , Jaclyn Miyamoto 1 , Paula Porras 1 , Zakk Walterscheid 1 , Carsten Schultz-Fademrecht 2 , Christ
Autor:
Dawn Jaquish, Evangeline Mose, Raymond W. Lam, Jaclyn Miyamoto, Jeffery Chakedis, Randall French, Patrick Holman, Andrew M. Lowy, Haleigh Howard, Zakk Walterscheid, Michele L. Babicky
Publikováno v:
Oncogene, vol 35, iss 25
Oncogene
Oncogene
The MST1R gene is overexpressed in pancreatic cancer producing elevated levels of the RON tyrosine kinase receptor protein. While mutations in MST1R are rare, alternative splice variants have been previously reported in epithelial cancers. We report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3922ee8401d48590dec6ebd96cb8dd48
https://escholarship.org/uc/item/1q16t7ct
https://escholarship.org/uc/item/1q16t7ct
Autor:
Dawn Jaquish, Jaclyn Miyamoto, Zakk Walterscheid, Jeffery Chakedis, Haleigh Howard, Evangeline Mose, Michele L. Babicky, Andrew M. Lowy, Patrick Holman, Randall French
Publikováno v:
Cancer Research. 75:A72-A72
Introduction:The RON tyrosine kinase receptor is increasingly overexpressed during progression to Pancreatic Intraepithelial Neoplasia (PanIN) and pancreatic duct adenocarcinoma (PDAC). RON expression in these neoplastic cells is associated with a hi